A cancer research program in Queensland has responded to the generosity of our members.
In the winter edition of The Road Ahead we reported on QIMR Berghofer’s frontier research designing supercharged immune cells, called CAR T cells, to treat the blood cancer, lymphoma.
A trial of CAR T cell therapy at the Royal Brisbane and Women’s Hospital has been remarkably successful for some patients.
QIMR Berghofer’s Dr Siok Tey appealed for donations to improve the therapy and help deliver a new trial for patients with the aggressive blood cancer myeloma. The appeal was a great success, and thanks to the generosity of RACQ members and others, more than $525,000 was donated.
Dr Siok Tey said she and her dedicated team were deeply grateful for the support.
“Thank you from the bottom of my heart for your enthusiastic and generous support of our research,” Dr Tey said.
“Your donations will help make this potentially life-saving immunotherapy better and, most importantly, help make it more accessible to Australian patients for whom it offers so much hope.”
Top photo: QIMR Berghofer’s Dr Siok Tey has thanked RACQ members for their support.
Thank you for your enthusiastic and generous support of our research
